Not yet recruiting
Major depression+2
Not yet recruitingStudy on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure
Registered drugNo placebo
Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure
Registered drugNo placebo
- Disease:Major depressionBipolar disorder+1
- Substances:ClozapineDuloxetine+11
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Clozapine



